LivaNova PLC (LIVN) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Livanova (LIVN) Q1 2026: Cardiopulmonary Output to Rise 60% by 2030 as Market Share Jumps
May 06, 2026
-
LIVN Q4 2025: Cardiopulmonary Upgrades Drive 13% Segment Growth as Epilepsy Access Expands
February 25, 2026
-
Livanova (LIVN) Q3 2025: Cardiopulmonary Revenue Jumps 16% as Essence Penetration Accelerates
November 05, 2025
-
LivaNova (LIVN) Q2 2025: Cardiopulmonary Revenue Surges 13% as Essence Upgrade Drives Multi-Year Growth
August 06, 2025
-
LivaNova (LIVN) Q1 2025: Cardiopulmonary Revenue Up 15% as Essence Rollout and Osprey Data Drive Guidance Lift
July 07, 2025